Skip to search formSkip to main contentSkip to account menu

Carboplatin/Etoposide/Melphalan Regimen

Known as: CEM, CEM Regimen 
A regimen containing carboplatin, etoposide and melphalan used for the treatment of childhood neuroblastoma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
1. Gage AA, Meenaghan MA, Natiella JR, Green GW Jr. Sensitivity of pigmented mucosa and skin to freezing injury. Cryobiology 1979… 
1988
1988
In contrast to methotrexate (MTX) and aminopterin (AMT), the 8-deaza analogues of these antifolates are not substrates for rabbit… 
Review
1986
Review
1986
Clinical measurements quantitating glucocorticoid receptor sites in leukemic blasts may give useful prognostic information. In… 
1986
1986
The exact route of metabolism of tiazofurin, a novel nucleoside with antitumor activity, is controversial. Using human cell lines… 
1986
1986
We analyzed the patterns of glycosphingolipids (GSLs) from a line of cells derived from a clone of the human T-cell leukemia… 
Highly Cited
1983
Highly Cited
1983
The antitumor activity of the C-nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (TR), was investigated in four human… 
1983
1983
Two different tetracyclic chromophoric analogues of actinomycin D have been synthesized by engaging two chromophoric DNA-binding… 
Highly Cited
1980
Highly Cited
1980
For cytoplasmic glucocorticoid–receptor complexes to enter and accumulate in the nucleus a temperature-dependent event… 
1979
1979
N-Trifluoroacetyladriamycin-14-valerate (AD32) and N-trifluoroacetyladriamycin (AD41) have been compared with Adriamycin and… 
1978
1978
Most CEM cases involve non-clinical mares with mild uterine inflammation. Asymptomatic mares can be infectious and remain…